News

Washington, DC—The SofPort Easy-Load Lens Delivery System (Bausch & Lomb) seems to be a giant step forward in IOL delivery. The system allows surgeons to load the lens into the inserter without the use of forceps, which eliminates damage to the IOL. The system is easy to use and cuts down surgical time, explained P. Dee G. Stephenson, MD, during the annual meeting of the American Society of Cata-ract and Refractive Surgery.

Washington, DC—Cataract surgery patients who received the AcrySof apodized diffractive IOL (ReSTOR, Alcon Laboratories) experienced a significantly higher degree of satisfaction with their vision compared with recipients of an acrylic foldable monofocal IOL, reported Robert J. Cionni, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Washington, DC—An IOL that blocks blue light leads to impairment of scotopic vision at the short wavelengths important for rod-mediated vision. The significance of this impairment in terms of the patient's visual performance remains to be determined, explained Gregory Jackson, PhD, at the American Society of Cataract and Refractive Surgery annual meeting.

Washington, DC—The improvements in health-related quality of life (HRQOL) made with the AcrySof Natural IOL (Alcon Laboratories), an IOL that attenuates blue light, were not statistically different from the results achieved with the AcrySof single-piece conventional IOL (Alcon). The Natural IOL did not adversely affect night driving or other common lifestyle events that are measured by a HRQOL questionnaire, reported Paul Ernest, MD, at the American Society of Cataract and Refractive Surgery annual meeting.

Washington, DC—The three-piece square-edge design of the Tecnis IOL platform (AMO) seems to protect the eye against development of posterior capsular opacification (PCO) by preventing migration of epithelial cells for at least 3 years after implantation, reported Michael Colvard, MD, FACS, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Washington, DC—Accumulating experience demonstrates the efficacy and safety of refractive lens exchange (RLE) performed with bimanual microincision phaco, said I. Howard Fine, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Washington, DC—Results of a clinical trial demonstrate the efficacy and safety of the investigational nonsteroidal anti-inflammatory drug (NSAID) nepafenac 0.1% ophthalmic suspension (Alcon Laboratories) for reducing anterior segment inflammation and minimizing pain after cataract surgery, said Stephen S. Lane, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Washington, DC—The combination of a new "ultra-sleeve" (Alcon Laboratories) with the Infiniti flare tip (Alcon) allows coaxial phacoemulsification to be performed with high efficiency through a 2.1-mm incision, said Richard J. Mackool, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Washington, DC—The introduction of a topical nonsteroidal anti-inflammatory drug (NSAID) 3 days before phacoemulsification produced excellent results in terms of surgical efficacy and outcomes, according to Eric D. Donnenfeld, MD, at the American Society of Cataract and Refractive Surgery annual meeting.

Washington, DC—"Cold" phaco can truly be performed using micropulse technology whereas operating with conventional pulse mode can result in significant heat generation and the potential for wound burn, said Aron D. Rose, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Registration is now open for the 2005 annual meeting of the American Academy of Ophthalmology (AAO). It is time to begin planning your schedule to ensure your place in the most popular courses and events, as well as securing reduced early-bird registration fees. Registration is easy and convenient from the academy's Web site, www.aao.org/annual_meeting.

Imagine a CME-accredited ophthalmology radio show. That's the idea behind As Seen From Here (www.AsSeenFromHere.com), a new weekly audio program of interviews with recent authors of articles in ophthalmology peer-review journals. The audio program, which is free, automatically loads onto the iPods and computers of ophthalmologists across the United States and in a growing number of countries throughout the world.

In the 1970s, when I began medical school, dire predictions of physician shortages abounded. Congress passed a law to get U.S. medical schools to solicit transfers of students from non-U.S. schools for their third and fourth years, so as to address the looming undersupply.

Washington, DC—The American Academy of Ophthalmology (AAO) is joining other professional organizations to support the "Children's Access to Vision Care Act of 2005," a bill that would provide $75 million in state grants for eye exams and other treatment for uninsured children who fail vision screenings.

Cleveland—A privately held biotechnology company said it has developed a proprietary non-viral nucleic acid nanoparticle technology that can introduce DNA into cells of the retina and other optic tissues.

San Francisco—Sirna Therapeutics' medication for the treatment of age-related macular degeneration (AMD) appears to be safe and well-tolerated, with all patients experiencing visual acuity stabilization so far, the company said.

New Orleans—More than 250 African-American men over age 50 took part in a glaucoma screening at Franklin Avenue Baptist Church here earlier this year.

Escondido, CA—Optelec U.S. Inc., a manufacturer of products for people who are blind or partially sighted, has purchased the Professional Products Division of Lighthouse International.

Baltimore—Elder abuse is a relatively common occurrence, with more than 1 million cases reported each year in the United States. In all likelihood, elder abuse is underreported, according to Myron Miller, MD.

Fort Lauderdale, FL—All indications point to the fact that inflammation is involved in complement activation in age-related macular degeneration (AMD), based on the results of recent research. In addition, the phenotype of drusen in a rare disease, membranoproliferative glomerulonephritis type II, is similar to that in AMD.

Washington, DC—Results of the 2004 American Society of Cataract and Refractive Surgery (ASCRS) survey of infectious keratitis after refractive surgery show there has been an end to the epidemic of atypical mycobacterial infections.

These observations—together with recent studies that have identified specific auto-antigens in melanin-containing cells—support the idea that VKH disease is an autoimmune disorder.

Chester, VA—Carl Zeiss has updated its company Web site to include an interactive vision demo section that explains eye anatomy, vision problems, Zeiss products, and more.

Ophthalmologists may feel that offering low vision care would be too time-consuming and not profitable.

Tehran, Iran—Hypothesizing that vitreous traction on the optic nerve head may have a role in the pathogenesis of nonarteritic anterior ischemic optic neuropathy (NAION), physicians in Iran performed a small, preliminary study of a new treatment in which vitrectomy was performed to release the traction.

Madison, WI—Diagnosing chronic progressive external ophthalmoplegia (CPEO) can be problematic because of overlap in clinical presentation with other ocular and neurologic diseases. In most cases, the disease is associated with a serious multi-system disease, but the ocular manifestations may be the first patient complaints.

Baltimore—Ophthalmologists must learn to recognize the signs and symptoms that indicate an impending stroke and initiate the appropriate evaluation for each patient, according to Preston C. Calvert, MD. He outlined a plan for ophthalmologists to implement to ensure a rapid neurologic consultation when patients present with risk factors for stroke.

Boston—Physicians must remain vigilant to detect nonglaucomatous pathologies that can mimic glaucoma and can use a set of time-tested recommendations to help determine which patients need a nonglaucomatous workup, said Louis R. Pasquale, MD, co-director, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston.

In medicine, as in many other professions, a gap exists between ideal or recommended behavior and what happens in the complex, messy "real world," where an infinite number of factors cause deviations from the desired goal. This is certainly true in glaucoma treatment, where various studies in recent years have shown that physicians fail to provide or document services such as optic nerve head photography as often as preferred practice guidelines recommend.

San Francisco—Capt. Steven Schallhorn, MD, addressed two timely issues at the annual San Francisco Cornea, Cataract, and Refractive Surgery Symposium. The first was the effect of pupil size on visual symptoms after LASIK and the second, custom-guided PRK procedures related to visual results and improved quality of vision.